CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates

CG Oncology, Inc. (CGON) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of$ 0.39. This compares to loss of $0.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -15.38%. A quarter ago, it was expected that this company would post a loss of$ 0.41 per share when it actually produced a loss of $0.48, delivering a surprise of -17.07%.Over the last four quarters, the company has surp ...